Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 bioRASI Names Compliance Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

bioRASI Names Compliance Officer

Judson to lead expansion efforts

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

David Judson has been appointed vice president and chief compliance officer at bioRASI. Mr. Judson will lead the company’s expansion efforts for worldwide operations and its strengthening of centralized Compliance, QA, Audit and Training infrastructure.
 
“We are extremely pleased to bring David Judson to lead our Compliance and Audit services branch,” said Dr. Boris Reznik, chairman of bioRASI. “Our acquaintance with David started six years ago when he conducted a sponsor audit of bioRASI. From the very beginning it was clear that we share similar views on the role and importance of quality functions at a CRO. As bioRASI’s quality infrastructure has expanded, it became essential to add the compliance officer of David’s caliber to our team.”
 
Prior to joining the company, Mr. Judson spent more than 25 years in leading compliance functions at big and small pharma companies, as well as CROs. Mr. Judson’s quality-focused experience covers R&D discovery, preclinical (GLP), Phase I-IV (GCP), clinical packaging, and pharmaceutical manufacturing (GMP and ISO 9000). He has conducted more than 1,500 audits in more than 25 countries.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters